These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 36258151)
1. Seizures in patients with IDH-mutated lower grade gliomas. Carstam L; Rydén I; Jakola AS J Neurooncol; 2022 Nov; 160(2):403-411. PubMed ID: 36258151 [TBL] [Abstract][Full Text] [Related]
2. Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With Bruno F; Pellerino A; Conti Nibali M; Pronello E; Cofano F; Rossi M; Levis M; Bertero L; Soffietti R; Cassoni P; Garbossa D; Bello L; Rudà R Neurology; 2024 May; 102(10):e209352. PubMed ID: 38684041 [TBL] [Abstract][Full Text] [Related]
3. Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification. Park YW; Kim S; Han K; Ahn SS; Moon JH; Kim EH; Kim J; Kang SG; Kim SH; Lee SK; Chang JH Eur Radiol; 2024 Feb; 34(2):1376-1387. PubMed ID: 37608093 [TBL] [Abstract][Full Text] [Related]
4. An extent of resection threshold for seizure freedom in patients with low-grade gliomas. Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599 [TBL] [Abstract][Full Text] [Related]
5. The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study. Corell A; Ferreyra Vega S; Hoefling N; Carstam L; Smits A; Olsson Bontell T; Björkman-Burtscher IM; Carén H; Jakola AS BMC Cancer; 2020 May; 20(1):450. PubMed ID: 32434559 [TBL] [Abstract][Full Text] [Related]
6. Intraoperative detection of IDH-mutant glioma using fluorescence lifetime imaging. Noble Anbunesan S; Alfonso-Garcia A; Zhou X; Bec J; Lee HS; Jin LW; Bloch O; Marcu L J Biophotonics; 2023 Apr; 16(4):e202200291. PubMed ID: 36510639 [TBL] [Abstract][Full Text] [Related]
7. MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma. Joyner DA; Garrett J; Batchala PP; Rama B; Ravicz JR; Patrie JT; Lopes MB; Fadul CE; Schiff D; Jain R; Patel SH Neuroradiology; 2023 Jan; 65(1):121-129. PubMed ID: 35953567 [TBL] [Abstract][Full Text] [Related]
8. Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentiles. Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Martinez-Zalacain I; Castell J; Camins A; Vidal N; Bruna J; Cos M; Perez-Lopez R; Oleaga L; Warnert E; Smits M; Majos C Eur Radiol; 2024 Aug; 34(8):5320-5330. PubMed ID: 38282078 [TBL] [Abstract][Full Text] [Related]
9. The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study. Mazzucchi E; Vollono C; Pauletto G; Lettieri C; Budai R; Gigli GL; Sabatino G; La Rocca G; Skrap M; Ius T J Neurol; 2022 May; 269(5):2627-2633. PubMed ID: 34693462 [TBL] [Abstract][Full Text] [Related]
10. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review. Berger TR; Wen PY; Lang-Orsini M; Chukwueke UN JAMA Oncol; 2022 Oct; 8(10):1493-1501. PubMed ID: 36006639 [TBL] [Abstract][Full Text] [Related]
11. IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas. Duan WC; Wang L; Li K; Wang WW; Zhan YB; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZY Medicine (Baltimore); 2018 Dec; 97(50):e13675. PubMed ID: 30558073 [TBL] [Abstract][Full Text] [Related]
12. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590 [TBL] [Abstract][Full Text] [Related]
13. [Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma]. Pan Y; Qi XL; Wang LM; Dong RF; Zhang M; Zheng DF; Chang Q; Zhong YF Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):292-8. PubMed ID: 24004584 [TBL] [Abstract][Full Text] [Related]
14. Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas. Liu Y; Chen H; Li G; Zhang J; Yao K; Wu C; Li S; Qiu X Cancer Biol Med; 2022 Nov; 19(10):1477-86. PubMed ID: 36350001 [TBL] [Abstract][Full Text] [Related]
15. Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype. Patel SH; Bansal AG; Young EB; Batchala PP; Patrie JT; Lopes MB; Jain R; Fadul CE; Schiff D AJNR Am J Neuroradiol; 2019 Jul; 40(7):1149-1155. PubMed ID: 31248860 [TBL] [Abstract][Full Text] [Related]
16. Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study. Habiba U; Sugino H; Yordanova R; Ise K; Tanei ZI; Ishida Y; Tanikawa S; Terasaka S; Sato KI; Kamoshima Y; Katoh M; Nagane M; Shibahara J; Tsuda M; Tanaka S Acta Neuropathol Commun; 2021 May; 9(1):95. PubMed ID: 34020723 [TBL] [Abstract][Full Text] [Related]
17. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy. Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953 [TBL] [Abstract][Full Text] [Related]
18. Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study. van der Vaart T; Wijnenga MMJ; van Garderen K; Dubbink HJ; French PJ; Smits M; Dirven CMF; Kros JM; Vincent AJPE; van den Bent MJ Clin Cancer Res; 2024 Sep; 30(17):3837-3844. PubMed ID: 38990096 [TBL] [Abstract][Full Text] [Related]
19. Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas. Hong JB; Roh TH; Kang SG; Kim SH; Moon JH; Kim EH; Ahn SS; Choi HJ; Cho J; Suh CO; Chang JH Cancer Res Treat; 2020 Oct; 52(4):1041-1049. PubMed ID: 32324987 [TBL] [Abstract][Full Text] [Related]
20. Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma. Wong D; Lee TH; Lum A; Tao VL; Yip S Acta Neuropathol Commun; 2022 May; 10(1):70. PubMed ID: 35526077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]